Dr. Pavlos Anastasiadis joined the Translational Focused Ultrasound Research Laboratory in the Department of Diagnostic Radiology and Nuclear Medicine at the University of Maryland School of Medicine in 2016. His primary research efforts are related to the pre-clinical and translational studies of focused ultrasound within the Focused Ultrasound Foundation-Designated Center of Excellence at the University of Maryland School of Medicine. His research efforts involve magnetic resonance imaging-guided focused ultrasound, targeted delivery of therapeutics, nanomedicine, cancer immunotherapy for brain tumors, blood-brain barrier and small GTPases. He has previously been a German Research Foundation Fellow, Max-Planck Foundation Fellow and a Fraunhofer-Gesellschaft Fellow. Prior to moving to Maryland, he worked at the National Cancer Institute-Designated University of Hawaii Cancer Center. Currently, as an NIH T32 Cancer Biology Fellow, he is associated with the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. Dr. Anastasiadis has been a member of the American Association for Cancer Research, the American Society for Biochemistry and Molecular Biology, the International Society for Electrical Bioimpedance, the Acoustical Society of America, the International Society for Therapeutic Ultrasound and the German Society for Cell Biology.